Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $4.35 USD
Change Today +0.06 / 1.40%
Volume 6.2M
SGYP On Other Exchanges
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

synergy pharmaceuticals inc (SGYP) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/31/15 - $4.68
52 Week Low
10/10/14 - $2.45
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

synergy pharmaceuticals inc (SGYP) Related Businessweek News

No Related Businessweek News Found

synergy pharmaceuticals inc (SGYP) Details

Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic constipation GI disorders; and for the treatment of constipation-predominant irritable bowel syndrome GI disorders. The company is also developing SP-333, which is in Phase II clinical trials to treat opioid induced constipation, as well as in Phase Ib clinical trials to treat ulcerative colitis. Synergy Pharmaceuticals Inc. is headquartered in New York, New York.

35 Employees
Last Reported Date: 03/16/15

synergy pharmaceuticals inc (SGYP) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $750.0K
Principal Financial Officer, Principal Accoun...
Total Annual Compensation: $276.0K
Chief Medical Officer and Executive Vice Pres...
Total Annual Compensation: $445.3K
Chief Scientific Officer
Total Annual Compensation: $392.0K
Compensation as of Fiscal Year 2014.

synergy pharmaceuticals inc (SGYP) Key Developments

Synergy Pharmaceuticals, Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

Synergy Pharmaceuticals, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company's net loss was $27,389,000 or $0.28 per share, as compared to a net loss of $16,225,000 or $0.18 per share, for the three months ended March 31, 2014. Loss from operations was $22,804,000 compared with $16,477,000 a year ago. Net cash used in operating activities during the three months ended March 31, 2015 was $23.1 million as compared to $19.9 million of cash used in operating activities during the three months ended March 31, 2014.

Synergy Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-20-2015 12:00 PM

Synergy Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-20-2015 12:00 PM. Venue: Sheraton New York Times Square Hotel, 811 Seventh Avenue, New York, New York, United States. Speakers: Gary S. Jacob, Chairman, Chief Executive Officer and President.

Synergy Pharmaceuticals, Inc. to Amend Second Amended and Restated Certificate of Incorporation

Synergy Pharmaceuticals, Inc. announced that, at the AGM to be held on June 8, 2015, it will approve to amend the company's Second Amended and Restated Certificate of Incorporation, as amended, to increase the number of shares of common stock authorized for issuance from 200,000,000 to 350,000,000.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SGYP:US $4.35 USD +0.06

SGYP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Actavis plc $301.35 USD +0.13
Almirall SA €18.36 EUR +0.04
Ironwood Pharmaceuticals Inc $13.83 USD +0.05
Shire PLC 5,555 GBp +15.00
Sucampo Pharmaceuticals Inc $15.85 USD -0.08
View Industry Companies

Industry Analysis


Industry Average

Valuation SGYP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SYNERGY PHARMACEUTICALS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at